House report: Top drugmakers spend more on investor perks than R&D ...Middle East

Washington Times - News
House report: Top drugmakers spend more on investor perks than R&D
Fourteen leading drugmakers spent billions more on stock buybacks and dividends than on research and development during the 2016-2020 period, House Democrats said Thursday in a report drafted to rally support behind a liberal plan to let Medicare negotiate down U.S. drug prices. House Oversight Committee Chairwoman Carolyn Maloney said ...

Hence then, the article about house report top drugmakers spend more on investor perks than r d was published today ( ) and is available on Washington Times ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( House report: Top drugmakers spend more on investor perks than R&D )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News